Liaison Tech partners with SAFE-BioPharma Association

Monday, February 13, 2012 03:06 PM

Liaison Technologies, a global provider of secure cloud-based integration and data management services, has partnered with the SAFE-BioPharma Association.

Through the partnership, Liaison’s clients and their partners can leverage the validation and security of the SAFE-BioPharma standard, which verifies and manages digital identities and signatures involved in electronic transactions.

“Liaison’s enablement of the SAFE-BioPharma standard in a cloud-based platform is important to life sciences organizations as they utilize this important technology,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. 

The standard was designed to speed transformation of the biopharmaceutical and healthcare communities to a fully digital environment, while mitigating legal, regulatory and other business risks associated with electronic transactions. Recognized by the DEA and in line with HIPAA regulations, the standard provides a way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions.

“Collaborating with SAFE-BioPharma shows an ongoing commitment to ensuring our cloud-based services are supported by industry standards that enhance the quality and security of patient and other sensitive data,” said Gary Palgon, Liaison’s vice president of healthcare solutions.

Earlier this year, Liaison announced a healthcare partner program in an effort to expand services available to clients so they can more easily exchange information in light of the HITECH Act and new models of care.

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs